Cheleste M. Thorpe

3.6k total citations
44 papers, 2.6k citations indexed

About

Cheleste M. Thorpe is a scholar working on Infectious Diseases, Endocrinology and Epidemiology. According to data from OpenAlex, Cheleste M. Thorpe has authored 44 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 22 papers in Endocrinology and 11 papers in Epidemiology. Recurrent topics in Cheleste M. Thorpe's work include Escherichia coli research studies (22 papers), Viral gastroenteritis research and epidemiology (19 papers) and Clostridium difficile and Clostridium perfringens research (17 papers). Cheleste M. Thorpe is often cited by papers focused on Escherichia coli research studies (22 papers), Viral gastroenteritis research and epidemiology (19 papers) and Clostridium difficile and Clostridium perfringens research (17 papers). Cheleste M. Thorpe collaborates with scholars based in United States, Australia and Germany. Cheleste M. Thorpe's co-authors include David W. K. Acheson, Bryan P. Hurley, Adrienne W. Paton, James C. Paton, Mary E. Wilson, Cynthia L. Sears, Kristine Johnson, Dakshina M. Jandhyala, Joanne Hughes and Wendy E. Smith and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Cheleste M. Thorpe

44 papers receiving 2.5k citations

Peers

Countries citing papers authored by Cheleste M. Thorpe

Since Specialization

Citations

This map shows the geographic impact of Cheleste M. Thorpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheleste M. Thorpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheleste M. Thorpe more than expected).

Fields of papers citing papers by Cheleste M. Thorpe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheleste M. Thorpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheleste M. Thorpe. The network helps show where Cheleste M. Thorpe may publish in the future.

Co-authorship network of co-authors of Cheleste M. Thorpe

This figure shows the co-authorship network connecting the top 25 collaborators of Cheleste M. Thorpe. A scholar is included among the top collaborators of Cheleste M. Thorpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheleste M. Thorpe. Cheleste M. Thorpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus 2023 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), Jonah Larkins‐Ford, Jacob A. Klickstein, Florian P. Maurer, David Stone, (unknown), Cheleste M. Thorpe, (unknown), Bree B. Aldridge	8
2	Citrobacter rodentium(ϕStx2dact), a murine infection model for enterohemorrhagic Escherichia coli 2021 ·Current Opinion in Microbiology ·Cheleste M. Thorpe, (unknown), Marcia S. Osburne, Sivapriya Kailasan Vanaja, John M. Leong	7
3	Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016 2020 ·Anaerobe ·David R. Snydman, L. A. McDermott, Stephen G. Jenkins, E. J. C. Goldstein, Robin Patel, Betty A. Forbes, Stuart Johnson, Dale N. Gerding, Cheleste M. Thorpe, Seth T. Walk	20
4	Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids 2020 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·(unknown), (unknown), Anne Kane, Nicholas Alden, Ming Lei, David R. Snydman, Richard Vickers, Kyongbum Lee, Cheleste M. Thorpe	33
5	Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin 2018 ·PLoS ONE ·Cheleste M. Thorpe, Anne Kane, Justin Chang, Albert Tai, Richard Vickers, David R. Snydman	43
6	A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation 2018 ·Anaerobe ·Bradley J. Gardiner, Cheleste M. Thorpe, (unknown), L. A. McDermott, Seth T. Walk, David R. Snydman	5
7	Selective method for identification and quantification ofBifidobacterium animalissubspecieslactisBB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 andLactobacillus rhamnosusGG 2017 ·Journal of Applied Microbiology ·Debra D. Poutsiaka, (unknown), L. A. McDermott, Lori Stern, Cheleste M. Thorpe, Anne Kane, (unknown), Julie McKinney, Lisa Davidson, (unknown), Barry R. Goldin, David R. Snydman	12
8	Preface 2013 ·Infectious Disease Clinics of North America ·David W. K. Acheson, (unknown), Cheleste M. Thorpe	2
9	Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin 2013 ·Cancer Biology & Therapy ·John Wong, (unknown), (unknown), Thomas Engstrøm, (unknown), Dakshina M. Jandhyala, Cheleste M. Thorpe, Bruce E. Magun, Lisa J. Wood	47
10	Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib 2012 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Cheleste M. Thorpe, Amrita Ahluwalia, Arlin B. Rogers, Fumiko Obata, (unknown), Glynis L. Kolling, Anne Kane, Bruce E. Magun, Dakshina M. Jandhyala	23
11	Ricin and Shiga Toxins: Effects on Host Cell Signal Transduction 2011 ·Current topics in microbiology and immunology ·Dakshina M. Jandhyala, Cheleste M. Thorpe, Bruce E. Magun	35
12	Tissue Factor–Dependent Procoagulant Activity of Subtilase Cytotoxin, a Potent AB₅Toxin Produced by Shiga ToxigenicEscherichia coli 2010 ·The Journal of Infectious Diseases ·Hui Wang, James C. Paton, Cheleste M. Thorpe, Claudine S. Bonder, Wai Yan Sun, Adrienne W. Paton	8
13	ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression 2008 ·Cellular Microbiology ·Dakshina M. Jandhyala, Amrita Ahluwalia, Tom G. Obrig, Cheleste M. Thorpe	88
14	Clathrin-dependent trafficking of subtilase cytotoxin, a novel AB₅toxin that targets the endoplasmic reticulum chaperone BiP 2008 ·Cellular Microbiology ·(unknown), James C. Paton, Cheleste M. Thorpe, Adrienne W. Paton	51
15	The Emerging Clinical Importance of Non-O157 Shiga Toxin--Producing Escherichia coli 2006 ·Clinical Infectious Diseases ·Joanne Hughes, Mary E. Wilson, Kristine Johnson, Cheleste M. Thorpe, Cynthia L. Sears	359
16	AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP 2006 ·Nature ·Adrienne W. Paton, Travis Beddoe, Cheleste M. Thorpe, James C. Whisstock, Matthew C. J. Wilce, Jamie Rossjohn, Ursula M. Talbot, James C. Paton	292
17	Shiga Toxin--Producing Escherichia coli Infection 2004 ·Clinical Infectious Diseases ·Cheleste M. Thorpe	137
18	Shiga toxins activate translational regulation pathways in intestinal epithelial cells 2004 ·Cellular Signalling ·(unknown), Brent Cochran, (unknown), Cheleste M. Thorpe	22
19	Expression of the highly polymorphic Cryptosporidium parvum Cpgp40/15 gene in genotype I and II isolates 2002 ·Molecular and Biochemical Parasitology ·Roberta M. O’Connor, Cheleste M. Thorpe, Ana Marı́a Cevallos, Honorine Ward	18
20	Shiga Toxins Do Not Directly Stimulate Alpha-Granule Secretion or Enhance Aggregation of Human Platelets 1999 ·Acta Haematologica ·Cheleste M. Thorpe, Robert Flaumenhaft, Bryan P. Hurley, Mary Jacewicz, David W. K. Acheson, Gerald T. Keusch	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact